Related Experiment Video
Updated: Sep 17, 2025

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Enhancing 3D dopamine transporter imaging as a biomarker for Parkinson's disease via self-supervised learning with
Jongjun Won1, Grace Yoojin Lee2, Sungyang Jo3
1Department of Convergence Medicine, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
None:
Accurate diagnosis and precise estimation of disease progression states are crucial for developing effective treatment plans for patients with parkinsonism. Although various deep learning-based computer-aided diagnostic models have demonstrated benefits, they have been relatively underexplored in parkinsonism owing to limited data and lack of external validation. We introduce the hierarchical wavelet diffusion autoencoder (HWDAE), a generative self-supervised model trained with 1,934 dopamine transporter positron emission tomography (DAT PET) images. HWDAE learns relevant disease traits during generative training, prior to supervision with human labels, as evidenced by its ability to synthesize realistic images representing different disease states of Parkinson's disease. The pretrained HWDAE is subsequently adapted for two differential diagnostic tasks and one disease progression estimation task, tested on images from two medical centers. Our training approach introduces a paradigm for deep learning research utilizing PET and expands the potential of DAT PET as a biomarker for Parkinson's disease.
More Related Videos
06:09Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
Published on: February 2, 2021
14:21Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013